VP R&D Peter Stein will speak at the 360 Degree Reproductive Medicine Symposium in Zurich, presenting findings from our clinical study with University Hospital Zurich, as well as discuss how wearables and big data are impacting clinical gynecology.
Ava is pleased to announce that we have been invited to present our research at the Swiss OBGYN conference in a special symposium sponsored by Bayer.
Renowned institutional investors and business angels invest USD $2.6 million in Ava. This large seed-round underlines the company’s ambition to become a relevant player in women’s health.
The US Ambassador to Switzerland, Suzan G. LeVine, the Swiss State Secretary for Education, Research and Innovation Mauro Dell’Ambrogio, and the Managing Director of Venture Kick Jordi Montserrat honor Ava as one of Switzerland’s most promising startup companies.
TechCrunch Disrupt San Francisco is one of the world’s most important tech events. The most innovative startups around the world apply to present. Ava made it among the 2.5% that have been accepted. Check here for further information.
Ava wins the biggest Swiss startup prize and gets awarded 130k CHF in total funding and access to a relevant network to further fuel its growth and revolutionize women’s health.
The largest Swiss telecom provider Swisscom has selected Ava among the top startups of Switzerland. As an award, Swisscom’s outpost in San Francisco will support Ava with the US market launch, and further strengthen Ava’s position in the tech community in Silicon Valley.
Among more than 200 of the finest Swiss startup companies, Ava has won the de Vigier Award. This is one of the most prestigious awards in the Swiss innovation ecosystem.
In context with future plans to introduce its solution in China, Ava has protected its technology in China. Supported by a renowned local attorney, the application will further strengthen Ava’s international IP-protection.